Home > Healthcare > Medical Devices > Surgical Devices > Heart Closure Devices Market

Heart Closure Devices Market Trends

  • Report ID: GMI6140
  • Published Date: Nov 2024
  • Report Format: PDF

Heart Closure Devices Market Trends

Technological advancements are significantly propelling growth in the market, enabling the development of safer, more effective, and minimally invasive solutions for patients with structural heart conditions.
 

  • Innovations in biomaterials have led to heart closure devices that are more biocompatible, reducing the risk of adverse reactions and enhancing patient outcomes. Modern devices now utilize materials that minimize blood clot formation and device-related infections. For instance, bioresorbable materials dissolve naturally over time, which is particularly beneficial in pediatric cases where long-term device implantation may not be ideal. These advancements have enhanced the safety profile of heart closure devices, increasing both patient and clinician confidence in their use.
     
  • Additionally, improvements in imaging technologies, including 3D echocardiography and intracardiac ultrasound, have transformed the precision with which heart defects can be visualized and treated. These advanced imaging systems provide real-time, high-resolution visuals of the heart's structure, allowing for accurate placement of closure devices and reducing procedural risks. The ability to more accurately locate and treat defects leads to better patient outcomes, driving further adoption of heart closure devices as the standard of care for structural heart abnormalities.
Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

The global heart closure devices industry was valued at USD 4 billion in 2024 and is expected to grow at a CAGR of 15.9% from 2025 to 2034, driven by the increasing prevalence of cardiovascular diseases and the rising preference for minimally invasive procedures.

The left atrial appendage (LAA) closure devices segment generated USD 2.2 billion in 2024, primarily due to their significant benefit in reducing stroke risk.

The North America heart closure devices market recorded USD 2.7 billion in revenue in 2024 and is anticipated to grow at a CAGR of 14.3% between 2025 and 2034, driven by the rising incidence of atrial septal defect (ASD) and patent foramen ovale (PFO).

Key players in the industry include Abbott Laboratories, AtriCure, Biosense Webster, Boston Scientific Corporation, Cardia, Heartstitch, Lepu Medical Technology (Beijing) Co., Ltd., LifeTech Scientific Corporation, Medtronic, and Occlutech.

Heart Closure Devices Market Scope

Buy Now


Premium Report Details

  • Base Year: 2024
  • Companies covered: 13
  • Tables & Figures: 104
  • Countries covered: 19
  • Pages: 130
 Download Free Sample